NRX Pharmaceuticals, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
NRXP, NRXPW on Nasdaq
Industry
Pharmaceutical Preparations
Location
1201 Orange Street, Suite 600, Wilmington, DE

Insiders trading volume in the past year

NRX Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
B Group, Inc. 10%+ Owner $7.56M Aug 18, 2025
Daniel Javitt 10%+ Owner $3.08M Nov 29, 2022
Jonathan Javitt Chairman and Chief Scientist, Director, 10%+ Owner $1.77M +$46.8K +2.71% Apr 9, 2025
Big Rock Partners Sponsor, LLC 10%+ Owner $266K May 24, 2021
BRAC Lending Group LLC 10%+ Owner $189K May 24, 2021
Robert Besthof Interim CEO $57K Mar 8, 2022
William Fricker CFO & Treasurer $39.7K May 24, 2021
Aaron Gorovitz Director $33.6K Aug 30, 2023
Daniel Troy Director $26.9K May 24, 2021
Stephen Willard CHIEF EXECUTIVE OFFICER, Director $16K Dec 16, 2022
Alessandra Daigneault General Counsel & Secretary $15.9K Aug 19, 2021
Seth Van Voorhees Chief Financial Officer $14.8K Dec 16, 2022
Michael Abrams Chief Financial Officer $10K Feb 7, 2025
Herbert Raymond McMaster Director $9.13K Aug 26, 2021
Patrick Flynn Director Apr 9, 2025
Sharon Glied Director Oct 21, 2022
Richard Narido Interim CFO Sep 13, 2023
Ira S. Strassberg Chief Financial Officer Mar 15, 2022
Janet Rehnquist Director Dec 28, 2023
Chaim Hurvitz Director Apr 9, 2025
Dennis McBride Director Apr 9, 2025

Recent Insider Transactions by Companies or Individuals for NRX Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.